Qiagen N.V.

This stock has a reasonable momentum. Qiagen N.V. is not very popular among insiders. Qiagen N.V. is a mediocre stock to choose.

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to tra...

News

Declining Stock and Decent Financials: Is The Market Wrong About Qiagen N.V. (NYSE:QGEN)?

Simply Wall St Qiagen (NYSE:QGEN) has had a rough week with its share price down 2.7%. But if you pay close attention, you might find...\n more…

Brokerages Set Qiagen (NYSE:QGEN) PT at $51.10

Zolmax Qiagen (NYSE:QGEN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Three...\n more…

Qiagen (NYSE:QGEN) Given Average Recommendation of "Moderate Buy" by Brokerages

Ticker Report Shares of Qiagen (NYSE:QGEN - Get Free Report) have been given an average rating of "Moderate Buy" by the nine brokerages that are currently covering the firm, Marketbeat.com reports. Three...\n more…

QIAGEN, Lilly to develop Alzheimer's risk detection test

Seeking Alpha - Healthcare QIAGEN, Lilly to develop Alzheimer's risk detection test...\n more…

QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's disease

Globe Newswire QIAGEN to develop the first QIAstat-Dx IVD panel for neurodegenerative applications // New QIAstat-Dx panel to identify APOE genotypes, one of many factors considered in the diagnosis of patients...\n more…

QIAGEN N.V. announces conversion price of new net share settled convertible bonds

Globe Newswire NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION...\n more…